Whole-cell and nuclear NADPH oxidases levels and distribution in human endocardial endothelial, vascular smooth muscle, and vascular endothelial cells

Canadian Journal of Physiology and Pharmacology

Volumn 91, Issue 1, 2013, Pages 71-79

  Ahmarani, Lena ^a   Avedanian, Levon ^a   Al Khoury, Johny ^a   Perreault, Claudine ^a   Jacques, Danielle ^a   Bkaily, Ghassan ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Ca2+; Confocal microscopy; Free radicals; Human endocardial endothelial cells; Human vascular endothelial cells; Human vascular smooth muscle cells; NOX; Nuclear Ca2+; Nuclear GPCR; ROS

Indexed keywords

CALCIUM; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 5; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL DENSITY; CELL ISOLATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; ENDOCARDIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELATIVE DENSITY; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WHOLE CELL;

CALCIUM; CELL NUCLEUS; CELLS, CULTURED; ENDOCARDIUM; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE; REACTIVE OXYGEN SPECIES;

EID: 84873600826     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2012-0265     Document Type: Article

References (50)

1. Al Ghouleh, I., Khoo, N.K., Knaus, U.G., Griendling, K.K., Touyz, R.M., et al. 2011. Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling. Free Radic. Biol. Med. 51(7): 1271-1288. doi:10.1016/j.freeradbiomed.2011.06.011. PMID:21722728.
2. Avedanian, L., Riopel, J., Bkaily, G., Nader, M., D'Orleans-Juste, P., and Jacques, D. 2010. ETA receptors are present in human aortic vascular endothelial cells and modulate intracellular calcium. Can. J. Physiol. Pharmacol. 88(8): 817-829. doi:10.1139/Y10-057. PMID:20725140.
3. Avedanian, L., Jacques, D., and Bkaily, G. 2011. Presence of tubular and reticular structures in the nucleus of human vascular smooth muscle cells. J. Mol. Cell. Cardiol. 50(1): 175-186. doi:10.1016/j.yjmcc.2010.10.005. PMID:20937284.
4. Baas, A.S., and Berk, B.C. 1995. Differential activation of mitogen-activated protein kinases by H2O2 and O2-in vascular smooth muscle cells. Circ Res. 77(1): 29-36. doi:10.1161/01.RES.77.1.29. PMID:7540516.
5. 2+-activated NADPH oxidase in testis, spleen, and lymph nodes. J. Biol. Chem. 276: 37594-37601. doi:10.1074/jbc.M103034200. PMID:11483596.
6. Bedard, K., and Krause, K.H. 2007. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87: 245-313. doi:10. 1152/physrev.00044.2005. PMID:17237347.
7. BelAiba, R.S., Djordjevic, T., Petry, A., Diemer, K., Bonello, S., et al. 2007. NOX5 variants are functionally active in endothelial cells. Free Radic. Biol. Med. 42: 446-459. doi:10.1016/j.freeradbiomed.2006.10.054. PMID:17275676.
8. Bendall, J.K., Cave, A.C., Heymes, C., Gall, N., and Shah, A.M. 2002. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation, 105(3): 293-296. doi:10.1161/hc0302.103712. PMID:11804982.
9. Bkaily, G. 1994, Ionic channels in vascular smooth. Edited by G. Bkaily Molecular Biology Intelligence Unit, Austin, Tex.
10. Bkaily, G., Gros-Louis, N., Naik, R., Jaalouk, D., and Pothier, P. 1996. Implication of the nucleus in excitation contraction-coupling of heart cells. Mol. Cell. Biochem. 154: 113-121. doi:10.1007/BF00226779. PMID:8717425.
11. Bkaily, G., Pothier, P., Orleans-Juste, P., Simaan, M., Jacques, D., Jaalouk, D., et al. 1997. The use of confocal microscopy in the investigation of cell structure and function in the heart, vascular endothelium and smooth muscle cells. Mol. Cell. Biochem. 172: 171-194. doi:10.1023/A:1006840228104. PMID: 9278244.
12. 2+ exchanger. Mol. Cell. Biochem. 188(1-2): 187-197. doi:10.1023/A: 1006806925739. PMID:9823024.
13. Bkaily, G., Jacques, D., and Pothier, P. 1999. Use of confocal microscopy to investigate cell structure and function. Methods Enzymol. 307: 119-135. doi:10. 1016/S0076-6879(99)07010-X. PMID:10506971.
14. Bkaily, G., Choufani, S., Hassan, G., El-Bizri, N., Jacques, D., and Orleans-Juste, P. 2000. Presence of functional endothelin-1 receptors in nuclear membranes of human aortic vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 36: S414-S417. doi:10.1097/00005344-200036001-00121. PMID:11078437.
15. Bkaily, G., Jacques, D., Hassan, G., Choufani, S., and D'Orleans-Juste, P. 2001. Using confocal imaging to measure changes in intracellular ions. In Receptors: structure and functions. Edited by C. Stanford and R. Horton. Oxford University Press, New York, N.Y. pp. 209-231.
16. Bkaily, G., Massaad, D., Choufani, S., Jacques, D., and Orleans-Juste, P. 2002. Role of endothelin-1 receptors in the sarcolemma membrane and the nuclear membrane in the modulation of basal cytosolic and nuclear calcium levels in heart cells. Clin. Sci. (Lond.), 103(Suppl. 48): 141S-147S. PMID:12193073.
17. Bkaily, G., Sleiman, S., Stephan, J., Asselin, C., Choufani, S., Kamal, M., et al. 2003. Angiotensin II AT1 receptor internalization, translocation and de novo synthesis modulate cytosolic and nuclear calcium in human vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 81(3): 274-287. doi:10.1139/y03-007. PMID:12733826.
18. Bkaily, G., Nader, M., Avedanian, L., Jacques, D., Perrault, C., Abdel-Samad, D., D'Orleans-Juste, P., et al. 2004. Immunofluorescence revealed the presence of NHE-1 in the nuclear membranes of rat cardiomyocytes and isolated nuclei of human, rabbit, and rat aortic and liver tissues. Can. J. Physiol. Pharmacol. 82: 805-811. doi:10.1139/y04-119. PMID:15523538.
19. + exchanger in nuclear membranes of heart, hepatic, vascular endothelial, and smooth muscle cells. Can. J. Physiol. Pharmacol. 84(3-4): 431-441. doi:10.1139/y06-002. PMID:16902588.
20. Bkaily, G., Avedanian, L., and Jacques, D. 2009. Nuclear membrane receptors and channels as targets for drug development in cardiovascular disease. Can. J. Physiol. Pharmacol. 87(2): 108-119. doi:10.1139/Y08-115. PMID:19234574.
21. Bkaily, G., Avedanian, L., Al-Khoury, J., Provost, C., Nader, M., D'Orléans-Juste, P., and Jacques, D. 2011. Nuclear membrane receptors for ET-1 in cardiovascular function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300(2): R251-R263. doi:10.1152/ajpregu.00736.2009. PMID:21084674.
22. Briones, A.M., Tabet, F., Callera, G.E., Montezano, A.C., Yogi, A., et al. 2011. Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR. J Am Soc Hypertens. 5(3): 137-153. doi:10.1016/j.jash. 2011.02.001. PMID:21419746.
23. Cave, A., Grieve, D., Johar, S., Zhang, M., and Shah, A.M. 2005. NADPH oxidasederived reactive oxygen species in cardiac pathophysiology. Philos. Trans.R. Soc. B Biol. Sci. 360(1464): 2327-2334. doi:10.1098/rstb.2005.1772.
24. Cheng, G., Cao, Z., Xu, X., van, Meir, E.G., and Lambeth, J.D. 2001. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene, 269: 131-140. doi:10.1016/S0378-1119(01)00449-8. PMID:11376945.
25. Crawford, D., Zbinden, I., Amstad, P., and Cerutti, P. 1988. Oxidant stress induces the proto-oncogenes c-fos and c-myc in mouse epidermalcells. Oncogene, 3: 27-32. PMID:1482049.
26. Garrido, A.M., and Griendling, K.K. 2009. NADPH oxidases and angiotensin II receptor signaling. Mol. Cell. Endocrinol. 302(2): 148-58. doi:10.1016/j.mce.2008.11.003. PMID:19059306.
27. Gorlach, A., Brandes, R.P., Nguyen, K., Amidi, M., Dehghani, F., et al. 2000. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res. 87: 26-32. doi:10.1161/01.RES.87.1.26. PMID:10884368.
28. Guzik, T.J., West, N.E., Pillai, R., Taggart, D.P., and Channon, K.M. 2002. Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension, 39(6): 1088-1094. doi:10.1161/01.HYP.0000018041. 48432.B5. PMID:12052847.
29. Guzik, T.J., Sadowski, J., Kapelak, B., Jopek, A., Rudzinski, P., et al. 2004. Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins. Arterioscler. Thromb. Vasc. Biol. 24: 1614-1620. doi:10.1161/01.ATV.0000139011.94634.9d. PMID:15256399.
30. Guzik, T.J., Chen, W., Gongora, M.C., Guzik, B., Lob, H.E., et al. 2008. Calciumdependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J. Am. Coll. Cardiol. 52(22): 1803-1809. doi:10.1016/j.jacc.2008.07.063. PMID:19022160.
31. 2+ in human endocardial endothelium. J. Cardiovasc. Pharmacol. 36: 397-400. doi:10.1097/00005344200036001-00116. PMID:11078432.
32. Jay, D.B., Papaharalambus, C.A., Seidel-Rogol, B., Dikalova, A.E., Lassegue, B., et al. 2008. Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells. Free Radic. Biol. Med. 45: 329-335. doi:10.1016/j. freeradbiomed.2008.04.024. PMID:18466778.
33. Krause, K.H. 2007. Aging: a revisited theory based on free radicals generated by NOX family NADPH oxidases. Exp. Gerontol. 42(4): 256-262. doi:10.1016/j.exger.2006.10.011. PMID:17126513.
34. Lambeth, J.D., Cheng, G., Arnold, R.S., and Edens, W.A. 2000. Novel homologs of gp91phox. Trends Biochem. Sci. 25(10): 459-461. doi:10.1016/S0968-0004(00) 01658-3. PMID:11050424.
35. Lassegue, B., and Clempus, R.E. 2003. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285: 277-297. doi:10.1152/ajpregu.00758.2002. PMID:12855411.
36. Li, J.M., and Shah, A.M. 2003. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J. Am. Soc. Nephrol. 14(8 Suppl. 3): S221-S226. doi:10.1097/01.ASN.0000077406.67663.E7. PMID:12874435.
37. Li, L., Fink, G.D., Watts, S.W., Northcott, C.A., Galligan, J.J., et al. 2003. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation, 107(7): 1053-1058. doi: 10.1161/01.CIR.0000051459.74466.46. PMID:12600921.
38. Nabeebaccus, A., Zhang, M., and Shah, A.M. 2011. NADPH oxidases and cardiac remodelling. Heart Fail. Rev. 16: 5-12. doi:10.1007/s10741-010-9186-2. PMID: 20658317.
39. Paffenholz, R., Bergstrom, R.A., Pasutto, F., Wabnitz, P., Munroe, R.J., et al. 2004. Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase. Genes Dev. 8(5): 486-491. doi:10.1101/gad.1172504. PMID: 15014044.
40. Pandey, D., Patel, A., Patel, V., Chen, F., Qian, J., et al. 2012. Expression and functional significance of NADPH oxidase 5 (Nox5) and its splice variants in human blood vessels. Am. J. Physiol. Heart Circ. Physiol. 302(10): H1919-H1928. doi:10.1152/ajpheart.00910.2011. PMID:22427510.
41. Petry, A., Weitnauer, M., and Görlach, A. 2010. Receptor activation of NADPH oxidases. Antioxid. Redox Signal. 13(4): 467-487. doi:10.1089/ars.2009.3026. PMID:20001746.
42. Provost, C., Choufani, F., Avedanian, L., Bkaily, G., Gobeil, F., and Jacques, D. 2010. Nitric oxide and reactive oxygen species in the nucleus revisited. Can. J. Physiol. Pharmacol. 88(3): 296-304. doi:10.1139/Y10-011. PMID:20393594.
43. Ruef, J., Peter, K., Nordt, T.K., Runge, M.S., Kübler, W., and Bode, C. 1999. Oxidative stress and atherosclerosis: its relationship to growth factors, thrombus formation and therapeutic approaches. Thromb. Haemost. 82: 32-37. PMID: 10695483.
44. Sasaki, H., Yamamoto, H., Tominaga, K., Masuda, K., Kawai, T., et al. 2009. NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts. J. Med. Invest. 56(1-2): 33-41. doi:10.2152/jmi.56.33. PMID:19262012.
45. Schluter, T., Zimmermann, U., Protzel, C., Miehe, B., Klebingat, K.J., et al. 2010. Intrarenal artery superoxide is mainly NADPH oxidase-derived and modulates endothelium-dependent dilation in elderly patients. Cardiovasc. Res. 85: 814-824. doi:10.1093/cvr/cvp346. PMID:19843513.
46. Shibanuma, R., Kuroki, T., and Nose, K. 1988. Induction of DNA replication and expression of proto-oncogenes c-myc and c-fos in quiescent Balb/3T3 cells by xanthine/xanthine oxidase. Oncogene, 3: 17-21. doi:10.1161/01.RES.70.3.593.
47. Touyz, R.M., Chen, X., Tabet, F., Yao, G., He, G., et al. 2002. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ. Res. 90: 1205-1213. doi:10.1161/01.RES.0000020404.01971.2F. PMID:12065324.
48. Williams, H.C., and Griendling, K.K. 2007. NADPH oxidase inhibitors: new anti-hypertensive agents? J. Cardiovasc. Pharmacol. 50: 9-16. doi:10.1097/FJC. 0b013e318063e820. PMID:17666910.
49. Wingler, K., Hermans, J.J., Schiffers, P., Moens, A., Paul, M., et al. 2011. NOX1, 2, 4, 5: counting out oxidative stress. Br. J. Pharmacol. 164(3): 866-883. doi:10.1111/j.1476-5381.2011.01249.x. PMID:21323893.
50. Zhang, X., Shan, P., Jiang, G., Cohn, L., and Lee, P.J. 2006. Toll-like receptor 4 deficiency causes pulmonary emphysema. J. Clin. Invest. 116(11): 3050-3059. doi:10.1172/JCI28139. PMID:17053835.